Celsius Holdings, Inc (NASDAQ: CELH)

Celsius Holdings, Inc (NASDAQ: CELH) specializes in developing, producing, marketing, and distributing functional energy drinks for a diverse consumer base. Its flagship product, CELSIUS, is promoted as a fitness beverage or supplement that, when combined with exercise, aims to boost metabolism, enhance fat burning, and provide sustained energy.

Recent Business and Financial Updates

• Strategic Acquisition: Celsius Holdings has announced a definitive agreement to acquire Alani Nutrition LLC for USD 1.8 billion, including USD 150 million in tax assets, resulting in a net purchase price of USD 1.65 billion through a mix of cash and stock. The deal merges two expanding energy drink brands, strengthening their position in the U.S. market and leveraging the growing demand for zero-sugar, functional beverages.
• Revenue Growth and Market Expansion: Celsius Holdings, Inc. reported full-year 2024 revenue of USD 1.36 billion, reflecting increased consumer demand for functional and health-conscious beverages. This represents a 3% year-over-year growth, driven by the company’s expanding market presence and strategic initiatives. International sales saw a significant 37% increase, reaching USD 74.7 million, as Celsius continued to strengthen its global footprint.
• Retail Performance and Market Share: The company’s retail sales in the U.S. increased by 22% compared to the prior year, contributing to a 160-basis-point increase in its market share to 11.8%. The brand accounted for 30% of total category growth, highlighting its competitive positioning in the energy drink market. Additionally, Celsius expanded its distribution points by 37%, increasing product accessibility and reinforcing its market penetration.
• Financial Results and Profitability: Despite revenue growth, the company reported a decline in net income, which fell from USD 226.8 million in 2023 to USD 145.1 million in 2024. Gross margin improved by 220 basis points to 50.2%, reflecting lower outbound freight costs and material expenses. However, selling, general, and administrative expenses increased by 73%, primarily due to accrued legal expenses, restructuring costs, and contractual obligations.
• Fourth Quarter Performance: Fourth-quarter revenue declined by 4% year-over-year, totaling USD 332.2 million, due to increased allowances from distributor incentive programs. International sales, however, surged by 39% compared to the prior year, driven by growth in key markets, including the UK, Ireland, France, Australia, and New Zealand. The gross profit margin for the quarter improved to 50.2%, supported by cost efficiencies in logistics and materials.
• Acquisition of Alani Nu: Celsius Holdings announced a definitive agreement to acquire Alani Nutrition LLC for USD 1.8 billion, including USD 150 million in tax assets, resulting in a net purchase price of USD 1.65 billion. This acquisition, comprising a mix of cash and stock, will combine two fast-growing brands in the functional energy beverage market. The transaction, approved by the Board of Directors, is expected to close in the second quarter of 2025, pending regulatory approvals.
• Strategic Outlook and Leadership Commentary: Chairman and CEO John Fieldly emphasized that the company’s strong financial results and expanded distribution underscore its growth strategy. The acquisition of Alani Nu aligns with Celsius’ vision of becoming a leading functional beverage brand in the global market. CFO Jarrod Langhans reiterated the company’s commitment to strategic investments, vertical integration, and capital-efficient expansion to sustain long-term growth and shareholder value.

Technical Observation (on the daily chart):

Celsius Holdings has been in a persistent downtrend over the past year, but recent price action suggests potential stabilization. The stock is consolidating around the USD 23-USD 25 support range, with increasing volume indicating renewed interest. The RSI at 54.82 shows neutral to slightly bullish momentum. A break above the 50-day moving average (USD 26.38) could signal a trend reversal, while failure to hold support may lead to further downside.

Individuals can evaluate the stock based on the support and resistance levels provided in the report in case of keen interest taking into consideration the risk-reward scenario. 

Markets are trading in a highly volatile zone currently due to certain macro-economic issues and prevailing geopolitical tensions. Therefore, it is prudent to follow a cautious approach while investing.

Related Risk: This report may be looked at from a high-risk perspective and a recommendation is provided for a short duration. This report is solely based on technical parameters, and the fundamental performance of the stocks has not been considered in the decision-making process. Other factors which could impact the stock prices include market risks, regulatory risks, interest rates risks, currency risks, social and political instability risks etc. 

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance level is February 20,2025. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Target Price refers to a price level that the stock is expected to reach as per the relative valuation method and or technical analysis taking into consideration both short-term and long-term scenarios.

Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the New York Stock Exchange (NYSE), NASDAQ Capital Markets (NASDAQ), and or REFINITIV. Typically, all sources (NYSE, NASDAQ, or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.